Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Space exoskeleton boosts astronaut precision in High-Gravity tests

NCT ID NCT07278245

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether training with an upper-limb exoskeleton improves fine motor control in high-gravity conditions, like those astronauts face. Twelve healthy adults performed a pointing task in a centrifuge, with one group trained using the exoskeleton and the other without. The goal was to see if the exoskeleton could be a useful training tool for space missions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Oct 2025

Finished

Jan 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Maximum weight of 90 kg * Maximum sitting butt-to-shoulder distance of 70 cm * Certified as healthy by a comprehensive clinical assessment * Normal or corrected to normal vision * Right-handed tested with Edinburgh-Handedness-Inventory-Test (≥6th percentile, on https://www.brainmapping.org/shared/Edinburgh.php) * Non smokers * No alcohol or drug dependence, no medical treatment on a regular basis * Affiliated to a Social Security system and, for non-French resident, holding a European Health Insurance Card (EHIC) or a Global Health Insurance Card (GHIC). * Free of any engagement during the study * Test subjects must be able to understand and speak English * Who agreed to take part in the study and signed the informed consent Exclusion Criteria: * Left-handed tested with Edinburgh-Handedness-Inventory-Test (\<6th percentile) * Subjects with experience in experiments on a short arm human centrifuge or under real hyper-gravity * Non-tolerance to the centrifugation * Any history or presence of clinically relevant chronic disease * Refusal to give permission to contact his general practitioner, * Subject who, in the judgment of the investigator, is likely to be non-compliant during the study, or unable to cooperate because of a language problem or poor mental development, * Subject in the exclusion period of a clinical research, * Subject who has received more than 6000 Euros within 12 months for being a research subject, * Subject who cannot be contacted in case of emergency, * Vulnerable people according to law "Code de la Santé Publique" (L1121-5 to L1121-8)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Motor learning and physiological adaptation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medes - Imps

    Toulouse, Occitanie, 31400, France